SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-030186
Filing Date
2023-06-27
Accepted
2023-06-27 17:05:16
Documents
13
Period of Report
2023-06-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K igms-20230623.htm   iXBRL 8-K 120892
2 EX-10.1 igms-ex10_1.htm EX-10.1 247095
  Complete submission text file 0000950170-23-030186.txt   515501

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT igms-20230623_pre.xml EX-101.PRE 9828
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT igms-20230623.xsd EX-101.SCH 2451
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT igms-20230623_lab.xml EX-101.LAB 13350
7 EXTRACTED XBRL INSTANCE DOCUMENT igms-20230623_htm.xml XML 4709
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39045 | Film No.: 231048354
SIC: 2834 Pharmaceutical Preparations